title: In brief: Uridine triacetate (Xuriden) for hereditary orotic aciduria.
mesh_terms: D000085:Acetates / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000284:Administration, Oral; D015415:Biomarkers / Q000652:urine; D016527:Drug Costs; D006801:Humans; D009962:Orotate Phosphoribosyltransferase / Q000172:deficiency*; D009963:Orotic Acid / Q000652:urine*; D009964:Orotidine-5'-Phosphate Decarboxylase / Q000172:deficiency*; D011686:Purine-Pyrimidine Metabolism, Inborn Errors / Q000175:diagnosis / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000652:urine; D016896:Treatment Outcome; D014529:Uridine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000191:economics / Q000627:therapeutic use*
chemical_list: D000085:Acetates; D015415:Biomarkers; C000609666:uridine triacetate; D009963:Orotic Acid; D009962:Orotate Phosphoribosyltransferase; D009964:Orotidine-5'-Phosphate Decarboxylase; D014529:Uridine